Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

To Evaluate if the Medication Gabapentin Lessens Vulvar Pain

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
El enlace se guarda en el portapapeles.
EstadoTerminado
Patrocinadores
Colleen Stockdale

Palabras clave

Abstracto

The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.

Descripción

There is not a "best" treatment plan for vulvar pain including vulvodynia (chronic vulvar pain) and vulvar vestibulitis syndrome (VVS, chronic vulvar pain localized to the vaginal opening). We propose that vulvodynia is a neuropathic pain (pain that effects the nervous system) as characterized by pain from stimuli that is not usually painful, stimuli that would not usually be painful causing significant pain, and burning pain. Gabapentin has been shown to be effective in treating chronic pain.

fechas

Verificado por última vez: 06/30/2017
Primero enviado: 10/17/2006
Inscripción estimada enviada: 10/17/2006
Publicado por primera vez: 10/18/2006
Última actualización enviada: 07/27/2017
Última actualización publicada: 07/30/2017
Fecha de los primeros resultados enviados: 03/29/2017
Fecha de los primeros resultados de CC enviados: 07/27/2017
Fecha de los primeros resultados publicados: 07/30/2017
Fecha de inicio real del estudio: 12/31/2006
Fecha estimada de finalización primaria: 02/29/2008
Fecha estimada de finalización del estudio: 02/29/2008

Condición o enfermedad

Vulvar Pain Symptoms
Vulvodynia (Chronic Vulvar Pain)

Intervención / tratamiento

Drug: Gabapentin

Drug: Placebo oral capsule

Fase

-

Grupos de brazos

BrazoIntervención / tratamiento
Active Comparator: Gabapentin
Gabapentin (Neurontin) titration and dosing for total of 8 weeks (Cross over)
Drug: Gabapentin
300 mg. capsules Dosage schedule for weeks 1 and 2 and weeks 12 and 13: day 1 you will take 1 capsule for the day day 2 you will take 1 capsule 2 times for that day days 3-6 you will take 1 capsule 3 times for those days days 7-9 you will take 1 capsule in am and 1 capsule at noon, 2 capsules at bedtime each day days 10-12 you will take 1 capsule in am and 2 capsules at noon and 2 capsules at bedtime each day days 13-14 you will take 2 capsules 3 times each day continue on 2 capsules 3 times each day for 6 weeks after maximum dose of 1800 mg is reached after weeks 2 and 13. at completion of study treatment you will titrate off study drug over a weeks time.
Placebo Comparator: Placebo oral capsule
Placebo titration and dosing for total of 8 weeks (Cross over)
Drug: Placebo oral capsule
Placebo capsules Dosage schedule for weeks 1 and 2 and weeks 12 and 13: day 1 you will take 1 capsule for the day day 2 you will take 1 capsule 2 times for that day days 3-6 you will take 1 capsule 3 times for those days days 7-9 you will take 1 capsule in am and 1 capsule at noon, 2 capsules at bedtime each day days 10-12 you will take 1 capsule in am and 2 capsules at noon and 2 capsules at bedtime each day days 13-14 you will take 2 capsules 3 times each day continue on 2 capsules 3 times each day for 6 weeks after maximum dose of 1800 mg is reached after weeks 2 and 13. at completion of study treatment you will titrate off study drug over a weeks time.

Criterio de elegibilidad

Edades elegibles para estudiar 18 Years A 18 Years
Sexos elegibles para estudiarFemale
Acepta voluntarios saludablessi
Criterios

Inclusion Criteria:

- All women, ages 18 years and older with the diagnosis of vulvodynia or VVS (by Friedrich's criteria), who present to the University of Iowa Vulvar Vaginal Disease Clinic.

Exclusion Criteria:

- Vulvar Vaginal Disease clinic patients who are pregnant, less than 3 months postpartum, breast-feeding, non-English speaking, or have contraindication to use of gabapentin due to allergy or renal disease (serum creatinine level greater than 1.4).

Salir

Medidas de resultado primarias

1. Change From Baseline in Vulvar Pain [19 weeks]

change in vulvar pain following gabapentin compared to placebo - will evaluate the efficacy of gabapentin to decrease vulvar pain compared to placebo. end of 1st treatment (after 8 weeks) and end of 2nd treatment (after 19 weeks). Pain was assessed using ordinal scale (0-10): 0 = no pain, 10 = most severe pain.

Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge